Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E, which includes both tocopherols and tocotrienols, has been investigated for its potential role in supporting prostate health, particularly regarding prostate cancer prevention. The interest in Vitamin E stems in part from its antioxidant properties, which are theorized to help protect cells, including those of the prostate, from oxidative stress and related damage. Early observational studies suggested that higher intakes of vitamin E might be associated with a reduced risk of prostate cancer. However, large-scale randomized controlled trials, such as the Selenium and Vitamin E Cancer Prevention Trial (SELECT), found that supplemental vitamin E did not reduce prostate cancer risk and, in fact, might slightly increase it in some groups. Studies specifically examining mixed tocopherols and tocotrienols are more limited, but some laboratory and animal models suggest tocotrienols may have anti-cancer properties. Nonetheless, there is insufficient high-quality clinical evidence to support the use of vitamin E supplementation for prostate health or cancer prevention in the general population. Most major health organizations do not recommend vitamin E supplementation for this purpose. Thus, the use of Vitamin E (mixed tocopherols and tocotrienols) for prostate support is based on limited scientific rationale, but current human evidence does not robustly validate its efficacy.

More about Vitamin E (Mixed Tocopherols and Tocotrienols)
More about Prostate

Other ingredients that support Prostate

Other body systems supported by Vitamin E (Mixed Tocopherols and Tocotrienols)

Products containing Vitamin E (Mixed Tocopherols and Tocotrienols)